Leukemia & Lymphoma Society (LLS): Acute Myeloid Leukemia (AML)

Funded
About
The Leukemia & Lymphoma Society (LLS): Acute Myeloid Leukemia (AML) program provides comprehensive support for patients undergoing treatment for blood cancer. By covering a wide range of drug products, including Gleevec, Cyclophosphamide, and Neupogen, among others, LLS ensures that patients have access to necessary medications. The program streamlines the application process, offering immediate approval and access to a virtual copay card for eligible applicants. Patients are encouraged to verify drug coverage by contacting LLS directly, ensuring that all prescribed treatments for their primary cancer diagnosis are included.
Insurance requirements: Commercially insured, Medicare / Medicaid, Underinsured
Enrollment Forms
Enrollment Form
Benefits
•$4000 annual maximum benefit
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: Yes
•Activation Required: No
Program Details
•Please note that specific drug coverage is not indicated on program website; drug coverage must be verified by calling program at 8775572672
•LLS covers all products prescribed by the patient’s physician to treat their primary cancer diagnosis classified as a chemotherapy or prescription related to their covered diagnosis
•All products must be covered by the patient’s primary insurance provider
•Patients, caregivers, pharmacies, and healthcare providers can apply by phone or online
•Patients must have a valid email address to register & providers will need their NPI
•Once registered, patients will receive an email directing to a website to create a password; application form can then be entered
•To apply, patient will need to supply SSN or Alien ID, DOB, diagnosis, insurance details (group, policy, and ID numbers), Medicare/Medicaid info, physician, and pharmacy details
•Once the application is submitted, the approval/denial or pending status will be provided immediately
•If the application is approved, the patient can begin using the award right away with the virtual pharmacy copay card that will be attached to the award message
•LLS will fax a physician's form to the treating HCP; the completed form must be received within 30 days of the approval, or the award will be closed, and no further claims may be submitted
•Any required documentation can be uploaded to the portal, as well as claim submissions and payment requests